Precifar S.a.

Calculating rank

USPTO Granted Patents = 7

Forward Citations = 351

Loading Chart...

3 inventors (with patents filed for the assignee):

André Lechot (4 out of 45 patents)

André Lechot (2 out of 5 patents)

Orlando Da Rold (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 6264647 - Instrument holder for surgical instrument (2001-07-24),

2. 6238398 - Surgical reamer (2001-05-29),

3. 6129732 - Surgical reamer (2000-10-10),

4. 6106536 - Surgical Reamer (2000-08-22),

5. 5968049 - Milling cutter for medical purposes (1999-10-19),

6. 5658290 - Assembly comprising reamer spindle and reamer for surgery (1997-08-19),

7. 5190422 - Device for the quick fastening of a tool intended to be driven in (1993-03-02),

Company Overview

Precifar S.a. is a leading provider of pharmaceutical products, offering a wide range of high-quality medications to consumers worldwide. With a focus on innovation and customer satisfaction, Precifar is committed to improving global health outcomes through its advanced drug formulations and cutting-edge research. The company's dedication to quality and reliability has earned it a strong reputation in the industry, making it a trusted partner for healthcare professionals and patients alike.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#3 in Orvin

#1,341 in Switzerland

Orvin, Switzerland

Precifar S.a.

Forward Citations = 351

3 inventors:

André Lechot (4 out of 45 patents)

André Lechot (2 out of 5 patents)

Orlando Da Rold (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Precifar S.a.. Retrieved from https://idiyas.com/company/precifar-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]